Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Ophthalmol ; 2017: 5231095, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29225964

RESUMEN

PURPOSE: To evaluate lipids and C-reactive protein serum levels in patients with pseudoexfoliation syndrome (PEX) in the Polish population. METHODS: 96 patients were studied with PEX and 79 control subjects. Total cholesterol, triglycerides, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, non-HDL-cholesterol and CRP serum levels, and TG/HDL-C and TC/HDL-C indexes were assessed. RESULTS: There were no significant differences in concentration of lipids and values of TC/HDL-C, TG/HDL-C, and non-HDL-C between PEX and control groups. High-sensitivity C-reactive protein was not increased in patients with PEX. CONCLUSIONS: Our results cast doubt on the opinion on the possible PEX and vascular diseases relation. Further studies on this subject are mandatory.

2.
Klin Oczna ; 113(4-6): 175-9, 2011.
Artículo en Polaco | MEDLINE | ID: mdl-21913452

RESUMEN

The pharmaceuticals inhibiting proliferation of epithelium cells or causing their death were tested in experimental studies on PCO prevention. The following antymetabolites were tested: 5-fluorouracil, dounomycin, methotrexat and colchicine, epithelial antibodies against epithelial cells, toxins, hyperosmolar agents and heparin, indomethacine and lignocaine. Moreover, gene therapy with the use of apoptose genes was applied. None of the attempts to prevent PCO was useful for effective and safe clinical treatment.


Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Antimetabolitos/administración & dosificación , Opacificación Capsular/prevención & control , Opacificación Capsular/terapia , Terapia Genética/métodos , Glucocorticoides/administración & dosificación , Facoemulsificación/métodos , Antiinflamatorios no Esteroideos/farmacología , Antimetabolitos/farmacología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Epitelio Corneal/efectos de los fármacos , Epitelio Corneal/patología , Humanos
3.
Klin Oczna ; 112(7-9): 257-62, 2010.
Artículo en Polaco | MEDLINE | ID: mdl-21121131

RESUMEN

The lens platform defines lens structure and lens material. Evolution of lens comprises change in their shape, angulation of haptens and transition of three-piece lens into one-piece lens. The lens fall into two categories: rigid (PMMA) and soft (siliconic, acrylic, colameric). The main lens maaterials are polymers (hydrophilic and hydrophobic). The lens platform has an effect on biocompatibility, bioadhesion, stability of lens in capsule, degree of PCO evolution and sensitiveness to laser damages.


Asunto(s)
Resinas Acrílicas/uso terapéutico , Materiales Biocompatibles/uso terapéutico , Cápsula del Cristalino/cirugía , Lentes Intraoculares/normas , Polimetil Metacrilato/uso terapéutico , Elastómeros de Silicona/uso terapéutico , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Diseño de Prótesis
4.
Klin Oczna ; 111(10-12): 369-74, 2009.
Artículo en Polaco | MEDLINE | ID: mdl-20169899

RESUMEN

The lens epithelial cells of A and E type are involved in pathogenesis of posterior capsule opacification (PCO). They undergo metaplasia into microfibroblasts, then migrate towards posterior capsule where they proliferate and form opacification. These processes are stimulated by cytokines and interleukines. The extracellular matrix which constitutes a scaffold for migration and attachment of epithelial cells plays an important role in PCO formation. Integrines intercede in this process.


Asunto(s)
Afaquia Poscatarata/patología , Cápsula del Cristalino/metabolismo , Cápsula del Cristalino/patología , Seudofaquia/patología , Animales , Extracción de Catarata/efectos adversos , Movimiento Celular , Células Epiteliales/metabolismo , Falla de Equipo , Matriz Extracelular/metabolismo , Fibroblastos/citología , Fibroblastos/metabolismo , Humanos , Integrinas/metabolismo , Metaplasia , Complicaciones Posoperatorias/patología
5.
Klin Oczna ; 109(10-12): 464-9, 2007.
Artículo en Polaco | MEDLINE | ID: mdl-18488398

RESUMEN

Posterior capsule opacification (PCO) is a late complication after the cataract surgery, currently occurring most often. The epithelial cells which migrate to the surface of the posterior capsule participate in the mechanism of PCO formation. Clinical opacification of the posterior capsule appears as the foggy form, creasing, pearl mass and fibrosis. PCO can be cured by laser or surgical capsulotomy. The factors influencing a size and intensity of PCO are as follows: age of patient, other diseases, method of surgery and type of the implanted artificial intraocular lens. Prevention against PCO during surgery should include accurate hydrodissection, removing of cortical mass, polishing of the capsule and intracapsular fixation of the lens. It is necessary to carry out further studies on possibilities of PCO prevention.


Asunto(s)
Extracción de Catarata , Epitelio Corneal/patología , Seudofaquia/etiología , Humanos , Seudofaquia/diagnóstico , Seudofaquia/prevención & control , Seudofaquia/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA